In this study, we found that administration of eNOS inhibitor L-NMMA significantly and partially abolished the beneficial effects of CYP2J3 gene delivery on hypertension induced by fructose intake, and its possible mechanism is associated with increased ET-1, ETA-receptor mRNA expression (data not shown). This evidence concerns the gene NOS3 and hypertensive disorder.